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Abstract The histidine-rich Ca2+ binding protein (HRC) re-
sides in the sarcoplasmic reticulum of muscle and binds Ca2+.
Since Ca2+ concentrations can regulate gene expression via
calcineurin, the mouse homologue of HRC (mHRC) was isolated
and characterized. mHRC was detected in muscle progenitor
cells, in primary clonal thymic tumors and a tumor cell line,
suggesting a broader role for mHRC than in Ca2+ storage during
muscle contraction. mHRC was present in the perinuclear region
of myoblasts. To examine if it can regulate gene expression,
mHRC was overexpressed in cells differentiating into cardiac
and skeletal muscle. mHRC had no effect on cardiogenesis or
myogenesis. Therefore, if mHRC plays a role in the regulation of
gene expression during cellular differentiation, it does not appear
to be either rate-limiting or inhibitory.
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1. Introduction
The sarcoplasmic reticulum plays an important role in the
regulation of Ca2 concentrations during muscle contraction
and relaxation. Ca2 is released by activation of the ryanodine
receptor and pumped back into the lumen of the sarcoplasmic
reticulum by the Ca2 ATPase (reviewed in [1]). Several pro-
teins reside in the lumen and are believed to help in regulating
this process by binding Ca2. These proteins include calse-
questrin, calreticulin and the histidine-rich Ca2 binding pro-
tein (HRC). Calreticulin is expressed ubiquitously while calse-
questrin and HRC are highly expressed in adult heart and
skeletal muscle [2^6].
The sarcoplasmic reticulum proteins have been shown to
play more complex roles than merely binding free Ca2. Cal-
reticulin has been shown not only to bind and regulate Ca2
in the endoplasmic reticulum (ER)/sarcoplasmic reticulum,
but also to be involved in the regulation of gene expression,
cell adhesion and protein folding [6]. Overexpression of calre-
ticulin inhibited the retinoic acid-induced di¡erentiation of
P19 cells into neurons and thus, a role in regulating gene
expression appears biologically relevant [7]. Similarly, overex-
pression of calsequestrin in murine cardiomyocytes results in
cardiac hypertrophy and modulated gene expression [8,9].
These results suggest that Ca2 storage proteins play an im-
portant role in regulating gene expression and are consistent
with the recent ¢ndings that Ca2 concentrations can regulate
muscle-speci¢c gene expression via the calcineurin/NFAT
pathway [10,11].
HRC, unlike calsequestrin and calreticulin, is a poor-
studied protein. It binds zinc, Ca2 and lipoproteins in vitro
although the biological signi¢cance of these properties is still
poorly understood [4,5,12]. HRC is hypothesized to be part of
the ryanodine receptor-dihydropyridine receptor complex
found in triad structures, which is involved in Ca2 release
[13,14]. Given the importance of the Ca2 storage proteins,
the mouse homologue of HRC (mHRC) has been cloned and
its tissue distribution, subcellular localization and e¡ect on
early muscle development have been examined.
2. Material and methods
2.1. Cloning and sequence analysis
In order to isolate a transcript overexpressed in TBLV-induced
thymic lymphomas [15], an adult mouse skeletal muscle library was
screened at high stringency with a unique 1 kb genomic probe from
the TBLV integration locus on the X-chromosome [16]. Three clones
were isolated and sequenced on both strands using standard tech-
niques and were found to encode mHRC. mHRC is not located on
the X-chromosome, but hybridized to the genomic fragment via GC-
rich regions.
2.2. Northern Blot analysis
Total RNA was isolated, Northern blots were performed and
probes were prepared as described previously [17]. P19 cells, with
and without the expression of myogenin, were harvested while grow-
ing in monolayer (day 0), while growing as aggregates in 0.8% DMSO
(days 1^4) and following aggregation (days 5 and 6) as described ([18],
Ridgeway and Skerjanc, unpublished results). Poly-A+ mRNA was
prepared from normal thymus and primary clonal thymic tumors
from TBLV-infected mice [16] using the FastTrack kit (Invitrogen,
Carlsbad, CA, USA). Multiple tissue Northern blots (MTN blots)
containing total RNA from normal human tissues (cat. # 7759-1
and 7760-1) and from eight di¡erent human cancer cell lines (cat.
# 7757-1) were obtained from Clontech Laboratories.
2.3. Cell culture and DNA transfection
P19 embryonal carcinoma cells and P19 (myogenin) stable cell lines
were cultured, di¡erentiated and transfected as described previously
([19,20], Ridgeway and Skerjanc unpublished data). Brie£y, P19 cells
were aggregated for 4 days in the presence of 0.8% dimethylsulfoxide,
prior to plating in tissue culture dishes. C2C12 cells were cultured
under growth conditions in 5% fetal calf serum:5% calf serum.
The plasmid construct PGK-HRC contains the pgk-1 promoter
driving the full length mHRC. PGK-HRC-myc has six myc-epitopes
inserted in frame into the KpnI site at 1151 bp in the acidic repeat
region of mHRC. Transient transfections were performed by the cal-
cium phosphate method [21] with either 4 Wg PGK-HRC-myc or 4 Wg
PGK-LacZ on cells growing exponentially on gelatin-coated cover-
slips. The transfected cells were ¢xed with 3% paraformaldehyde
and membranes were permeabilized using 0.1% Triton X-100/PBS.
Immuno£uorescence was performed as described previously [22]. Im-
muno£uorescent images were visualized with a Zeiss Axioskop mi-
croscope, captured with a Sony 3CCD color video camera, processed
using Northern Exposure, Adobe photoshop and Corel Draw soft-
ware and printed with a dye sublimation phaser 450 Tektronic printer.
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Stable P19 cell lines expressing mHRC were created by transfecting
10 Wg PGK-HRC, 1 Wg PGK-puromycin, 2.5 Wg B17 [23] and 1 Wg
PGK-LacZ into P19 cells. High expressing P19 cell lines were isolated
and examined for their ability to di¡erentiate as described previously
[17]. Stable myoblast cell lines expressing mHRC were created by
transfecting 10 Wg PGK-mHRC, 1 Wg PGK-puromycin and 1 Wg
PGK-LacZ. Myoblasts were selected in puromycin for 1 week, trans-
ferred into di¡erentiation media containing 2% horse serum for 4 days
and colonies containing di¡erentiated myotubes were counted.
3. Results and discussion
The mHRC [5,24] was cloned (GenBank accession number
AF158597) and its sequence analyzed (Fig. 1). The longest
clone of mHRC was 2270 bp and encoded a protein of 726
amino acids. mHRC, like the rabbit and human homologues,
contains a conserved N-terminal signal sequence (amino acids
1^28), an acidic repeat region (amino acids 213^481), a cys-
teine repeat region (amino acids 654^700) and a stretch of 13
glutamic acid residues (amino acids 590^602).
The cysteine-rich region contains the highest amino acid
homology between the three species, with 81 or 86% homol-
ogy between mHRC and the rabbit or human homologues,
respectively. This region seems to be involved in binding Zn2
and LDL [4,5,12]. Since a prosite scan (Lasergene software,
DNAStar, Madison, WI, USA) identi¢es it as an EGF-like
cysteine repeat domain, this region may be involved in pro-
tein-protein interactions. The amino-terminal domain is less
conserved, 66 or 56% homology between mHRC and the rab-
bit or human homologues, respectively. This domain appears
to encode a hydrophobic signal sequence for translocation
into the ER.
The acidic repeat region is the least conserved, but a careful
examination of the acidic repeat sequences revealed a consen-
sus sequence for two types of repeats, type A and B, described
previously [5,24] (Fig. 2). The consensus sequence for the type
A human and rabbit repeats both had similarity indices of
67% to the consensus sequence for the mouse type A repeat,
by a Lipman-Pearson protein alignment [25]. The consensus
sequences for the type B human or rabbit repeats had simi-
larity indices of 44 or 36%, respectively, to the mouse con-
sensus sequence. The overall pattern of repeats was more sim-
ilar for mouse and human than for rabbit and human. These
acidic repeats are believed to bind Ca2 with a low a⁄nity [5].
In agreement with results found previously [5], an examina-
tion of the expression pattern of HRC in adult human tissues
showed high levels of HRC in heart and skeletal muscle (Fig.
3A). No mHRC expression was detected in colon or small
intestine, tissues rich in smooth muscle. A more in-depth anal-
ysis of the expression pattern showed high levels of HRC
transcripts in primary clonal thymic tumors (Fig. 3B) and in
the chronic myelogenous leukemia cell line, K-562 (Fig. 3C).
Therefore, mHRC is expressed in speci¢c types of cancer cells
Fig. 1. The nucleotide (top line) and amino acid (bottom line) sequences of murine HRC. The N-terminal signal sequence is underlined, the
acidic repeat region is marked by the open box and the cysteine residues in the cysteine repeat region are circled.
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and is not limited to mature muscle ¢bers. In addition, an
examination of HRC expression during the di¡erentiation of
P19 cells into cardiac muscle indicated that HRC was ex-
pressed on day 4 of di¡erentiation, a full day before the ¢rst
muscle-speci¢c structural gene, cardiac K-actin, is expressed
(Fig. 4). Using a P19 cell line overexpressing myogenin
(Ridgeway, A.G. and Skerjanc, I.S., unpublished data) to ex-
amine di¡erentiation into skeletal muscle, HRC was present
on day 3, 3 full days before the skeletal muscle-speci¢c
marker, myosin light chain (MLC) 1/3, was expressed (Fig.
4). Therefore, mHRC is expressed very early during cardiac
and skeletal muscle development. Taken together, these ¢nd-
ings indicate that mHRC expression is not restricted to adult
muscle ¢bers, suggesting a role for mHRC in addition to
regulating Ca2 concentrations during adult muscle ¢ber con-
traction.
The ¢rst approach taken to examine other biological roles
for mHRC was to determine its subcellular localization in the
absence of a sarcoplasmic reticulum. This localization was
compared to that known for calsequestrin and calreticulin.
Calsequestrin does not have a KDEL sequence but has been
localized to dense vacuoles within the ER when overexpressed
in myoblasts [26,27]. It is hypothesized that these vacuoles
represent the genesis of a sarcoplasmic reticulum. In contrast,
the ubiquitously expressed calreticulin has a KDEL sequence,
localizes to the ER and does not form dense vacuoles when
overexpressed in myoblasts. A myc-epitope-tagged mHRC
was transfected into P19 cells (data not shown) and myoblasts
(Fig. 5) and examined by immuno£uorescence. In both of
these cases, the majority of mHRC protein, which does not
have a KDEL sequence, exhibited a perinuclear expression
pattern similar to the di¡use pattern found for calreticulin.
Therefore, mHRC is similar to calreticulin in the di¡use pat-
tern of ER expression even though calreticulin has a KDEL
sequence and mHRC does not. Localization to the perinuclear
region is consistent with a role for mHRC in regulating cyto-
solic Ca2 concentrations by binding Ca2 in the lumen of the
ER.
The calcineurin/NFAT pathway has been implicated in the
Fig. 2. Acidic repeats conserved across species in HRC. The type A
and B repeats were used as templates to determine repeats found
within mHRC. The murine type A and B amino acid sequences and
residues are listed along with the overall consensus sequence for
mouse, human and rabbit. The overall repeat patterns are shown at
the bottom of the ¢gure. Fig. 3. HRC is overexpressed in TBLV-induced T-cell thymic lym-
phomas and a chronic myelogenous leukemia (CML) line. (A)
MTN blots from Clontech were probed with human HRC (hHRC).
The blots contain total RNA from the various normal human tis-
sues indicated. PBL: peripheral blood leukocytes. (B) A Northern
blot of poly-A+ RNA from normal thymus (lane 1) and tumors
from three separate mice infected with TBLV (lanes 2^4) was
probed with mHRC. (C) A MTN blot (Clontech) containing total
RNA from eight cancer cell lines was probed with hHRC. HL-60:
promyelocytic leukemia cell line; CML K-562: chronic myelogenous
leukemia cell line; MOLT-4: lymphoblastic leukemia cell line;
BLR: Burkitt’s lymphoma Raji cells ; SW 480: colorectal adenocar-
cinoma cell line; A549: lung carcinoma cell line; G361: melanoma
cell line. All blots are standardized to actin.
Fig. 4. HRC is expressed early during skeletal and cardiac muscle
development in P19 cells. Identical Northern blots containing total
RNA from a time course of P19 cell di¡erentiation (see Section 2)
were probed with K-cardiac actin, MLC1/3, mHRC and 18S as indi-
cated.
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regulation of muscle-speci¢c gene expression [10,11]. Since
this pathway is sensitive to cytosolic Ca2 levels, the ability
of mHRC to a¡ect gene expression was examined. mHRC
was overexpressed in P19 cells and myoblasts in an attempt
to modulate their di¡erentiation programs. Di¡erentiation
was monitored by cardiac K-actin transcript levels and by
counting colonies containing myotubes. No level of overex-
pression of mHRC resulted in a signi¢cant, reproducible
change in the extent of di¡erentiation of either P19 cells or
myoblasts into cardiac or skeletal muscle, respectively (data
not shown). In contrast, the overexpression of calreticulin in-
hibits the retinoic acid-induced di¡erentiation of P19 cells into
neurons [7], while overexpression of calsequestrin in transgen-
ic mice results in the induction of a fetal gene expression
program and cardiac hypertrophy [8,9]. Furthermore, mice
lacking calreticulin are not viable and are defective in their
cardiac development [28]. Subsequently, although calseques-
trin and calreticulin have been shown to regulate gene expres-
sion, our results indicate no e¡ect of mHRC overexpression.
It is possible that the loss of mHRC expression via targeted
gene disruption would reveal a biological role for mHRC not
observed in the overexpression studies presented here.
In summary, mHRC has an intriguing tissue distribution
suggestive of a role in the control of gene expression during
cell proliferation/di¡erentiation. Subcellular localization stud-
ies show that mHRC is present in the perinuclear region,
consistent with a role in the regulation of Ca2 stores. How-
ever, overexpression of mHRC during cardiac and skeletal
muscle development did not result in a signi¢cant acceleration
or inhibition of cardiogenesis or myogenesis. Therefore, if
mHRC plays a role in the regulation of muscle-speci¢c gene
expression, it is neither rate-limiting nor inhibitory.
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Fig. 5. HRC protein is perinuclear in myoblasts prior to terminal
di¡erentiation. C2C12 myoblasts were transiently transfected with a
myc-tagged mHRC. (A) shows a phase contrast view of the trans-
fected cells. (B) shows the perinuclear localization of HRC in a
transfected cell using a monoclonal anti-myc antibody (9E10).
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